Market Overview

The Latin America hypodermic syringes and needles market size was valued at USD 416.8 Million in 2025. Forecasts by IMARC Group project the market to grow to USD 532.9 Million by 2034, at a CAGR of 2.77% during the 2026-2034 period. Growth is driven by expanding vaccination programs, increased prevalence of chronic diseases, improving healthcare infrastructure, government initiatives for safe injection practices, innovations in needle design, and growing awareness regarding needlestick injury prevention.

Study Assumption Years

Base Year: 2025

Historical Years: 2020-2025

Forecast Period: 2026-2034

Latin America Hypodermic Syringes and Needles Market Key Takeaways

The market size was USD 416.8 Million in 2025.

The CAGR is 2.77% for the forecast period 2026-2034.

The forecasted market value is USD 532.9 Million by 2034.

Expanding vaccination programs, such as influenza vaccine doses in Argentina increasing from 1.2 million to over 4 million by 2025, boost market growth.

Increased government spending enhances healthcare infrastructure and medical supply accessibility.

Governments are fostering partnerships with suppliers, like the USD 40 million allocation by Brazil for aeromedical goods and services.

Emphasis on sustainability has led to developments of biodegradable and recyclable syringes and needles, alongside regional eco-labeling initiatives.

Sample Request Link: https://www.imarcgroup.com/latin-america-hypodermic-syringes-needles-market/requestsample

Market Growth Factors

Governments operate vaccination programs to meaningfully demand syringes and needles. E.g. In Argentina it is estimated that people will demand influenza vaccine syringes, with the demand increasing from 1.2 million doses to over 4 million doses by 2025, while availability increases and cost reduces. Argentina's National Ministry of Health and the Pan American Health Organization (PAHO) jointly acted to promote access toward safe and affordable health technologies, also they campaigned for public health focused on preventing communicable diseases like influenza and COVID-19. This increased demand and stabilized the market, in addition they partnered internationally with medical manufacturers so supply stayed consistent.

Investing more within the healthcare system also helps people access syringes and needles to receive routine medical care and vaccination. The region's government continues to make syringes and needles available. ITA states that the 2024 Brazil aeromedical trade mission connects U.S. suppliers with entry points into Brazil's growing aeromedical market. The Brazilian government, having budgeted USD 40 million for aeromedical equipment, therefore creates a market for procurements. These create closer ties to medical devices producers, and they ensure a reliable supply of quality goods.

Due to knowledge in people regarding environmental issues, healthcare facilities and manufacturers use more environmentally friendly materials and processes. The Environmental Alliance of America started in 2024. It is the first eco-label in Latin America. The United Nations Environment Programme or UNEP gave support. The German government gave money. The directive will do more than promote sustainable trade. It will also empower more than 450 million consumers with better information on the environmental impact of products and ease the development of biodegradable and recyclable syringes and needles. Regulatory bodies are promoting sustainable manufacturing practices and incentivizing stakeholders toward investment in a sustainable healthcare system through eco-friendly solutions.

Market Segmentation

Product Insights:

Hypodermic Syringes: The market includes conventional syringes and safety syringes, which are further divided into retractable safety syringes and non-retractable safety syringes.

Hypodermic Needles: This segment consists of conventional needles and safety needles.

End Use Insights:

The market is segmented by end use into hospitals, clinics, ambulatory surgical centers, veterinary, home care, and others.

Country Insights:

The report covers key regional markets such as Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others.

Regional Insights

Brazil, Mexico, Argentina, Colombia, Chile, Peru and other Latin American countries form the major regional markets for hypodermic syringes and needles. The market is driven by increasing healthcare infrastructure investments and government health initiatives in these countries, supporting steady demand growth. No additional specific statistics like market shares or CAGR by country were provided in the source.

Recent Developments & News

September 2024: The FDA approved B. Braun Medical's Introcan Safety 2 Deep Access IV Catheter, extending catheter dwell length from approximately 3.8 days to 5.7 days. This device minimizes blood exposure and cleanup with multi-access blood control and automatic passive needlestick protection, targeting patients with difficult vascular access.

August 28, 2024: The Brazilian Secretariat of International Trade (SECEX) launched an antidumping investigation on hypodermic needle imports from China. Initiated by Becton Dickinson Indústrias Cirúrgicas Ltda., this probe concerns products classified under NCM code 9018.32.19, with an alleged dumping margin of USD 16.93 per kg (261.7%). Stakeholders were invited to participate by September 17, 2024.

Key Players

B. Braun Medical

Becton Dickinson Indústrias Cirúrgicas Ltda.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.